Recombinant retroviral vectors usually encode the genes of interest in
place of the viral structural genes, which must be provided in trans.
These viruses are therefore defective for replication: infected cells
cannot produce progeny virus. However in some cases it may be desirab
le to generate virus from an infected cell clone displaying a phenotyp
e of interest. We describe a rapid method for producing virus, which i
nvolves fusing the infected cells to fresh packaging cells. Stable pro
ducer lines are generated after fusion by co-selecting for the Ecogpt(
+) marker in the packaging cells and the G418 resistance (neo(r)) mark
er in the infected cells. We have used this method to develop cell lin
es that produce retroviruses encoding a Leu 61-activated c-Ha-ras onco
gene as well as a neo(r) gene. The viruses confer oncogenic transforma
tion on 95%-100% of infected target cells as assayed by altered morpho
logy, focus formation and soft agar growth.